MUMBAI, India, Oct. 5 -- Intellectual Property India has published a patent application (202541030314 A) filed by Dr. Reddy'S Laboratories Ltd on March 28, 2025, for Oral Dosage Forms Of Glp-1/Gip Dual Agonists.
Inventors include Vijaya Deepthi Kurivella; Anup Avijit Choudhury; Dr Saurabh Vijay Shah; Sangmesh Mallikarjun Chaudhari; and Dr Venkat Ramana Naidu.
The application for the patent was published on October 02, 2026, under issue no. 40/2026.
Abstract: Oral dosage forms of GLP-1/GIP agonists ABSTRACT The present invention discloses a stable stable pharmaceutical formulation of GIP/GLP-1 dual agonists and one or more permeation enhances, and process for their preparation. Oral administration of the formulations of the present invention can be used for the treatment of type 2 diabetes as well as a variety of other conditions.
Disclaimer: Curated by HT Syndication.
